Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required) | RFA-MH-18-702 | NIMH | Feb 19, 2021 | R61/R33 |
Early Stage Testing of Pharmacologic or Device -based Interventions for the Treatment of Mental Health Disorders (R33- Clinical Trial Required) | RFA-MH-18-703 | NIMH | Feb 19, 2021 | R33 |
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) | RFA-OD-19-029 | ORWH | Nov 27, 2021 | R01 |
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) | RFA-OD-20-003 | NIH | Nov 4, 2021 | R61/R33 |
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) | RFA-OD-20-004 | NIH | Nov 4, 2021 | R21 |
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) | RFA-OD-20-005 | NIH | Nov 4, 2021 | R01 |
Small Research Grants for Analyses of Down Syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed) | RFA-OD-20-006 | NIH | Nov 4, 2021 | R03 |
From Genomic Association to Causation: A Convergent Neuroscience Approach to Linking Levels of Analysis for Understanding Neuropsychiatric Disorders (U19 Clinical Trial Optional) | RFA-MH-21-165 | NIMH | Mar 18, 2021 | U19 |